Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma
Clinical trial NCT05561049 · UNKNOWN
Trial details
- NCT number
- NCT05561049
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-01
- Primary completion
- 2024-09-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.